近几十年来，被诊断患有急性淋巴细胞白血病 (ALL) 的儿童的存活率显着提高，因此人们的注意力转向了解癌症治疗的副作用。化疗的副作用可能会影响肌肉状态并降低运动能力。此次范围界定审查旨在绘制精细运动技能评估中使用的不同工具的证据广度、上肢力量的程度和精细运动表现，强调可能影响这些技能的潜在风险因素。2023 年 3 月，全面通过在 PubMed、Science Direct、Scopus、Web of Science 和 PEDro 数据库中搜索，确定了检查精细运动表现和/或上肢力量的文本研究。根据纳入和排除标准对所选研究的标题和摘要进行筛选。检索得到初步418次引用，最终纳入26篇同行评审文章。关于评估精细运动技能的方法观察到相当大的异质性。本综述的结果表明，患有 ALL 的儿童和青少年在治疗期间或停止治疗后经历了精细运动限制和上肢无力。本范围综述对解决 ALL 儿科人群精细运动困难的文献进行了广泛的概述。结果强调需要将力量训练和职业治疗训练结合起来，以保持肌肉力量并最大限度地减少化疗过程中未来的精细运动问题。关于可能损害肌肉力量和运动表现的风险因素的证据很少。© 2024。作者。

Survival rates for children diagnosed with acute lymphoblastic leukemia (ALL) have increased significantly over recent decades, and thus attention shifted toward understanding the adverse effects of cancer treatment. Chemotherapy has side effects that could affect muscle state and diminish motor performance. This scoping review was conducted to map the breadth of evidence for different tools used in fine motor skills assessment, the extent of upper extremity strength, and fine motor performance, highlighting the potential risk factors that may influence these skills.In March 2023, full-text studies that examined fine motor performance and/or upper extremity strength were identified via searches in PubMed, Science Direct, Scopus, Web of Science, and PEDro databases. The titles and abstracts of selected studies were screened according to the inclusion and exclusion criteria.The search yielded initial 418 citations and 26 peer-reviewed articles were finally included in the review. Considerable heterogeneity was observed regarding the methods of evaluating fine motor skills. The results of this review indicate that children and adolescents with ALL experienced fine motor limitations and upper extremity weakness either during or after cessation of treatment.This scoping review presents a broad overview of the literature addressing fine motor difficulties in the pediatric population with ALL. Results accentuate the need to incorporate strengthening and occupational therapy training to preserve muscle strength and minimize future fine motor problems along the course of chemotherapeutic treatment. Little evidence was reported regarding the risk factors that may impair muscle strength and motor performance.© 2024. The Author(s).